×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Pr Roman Rouzier

Intervenants :
Pr Emmanuel Barranger, Centre Antoine Lacassagne, Nice
Pr Jean-Marc Classe, Institut de Cancérologie de l'Ouest, Nantes
Dr Joana Ribeiro, Institut Gustave Roussy, Paris
Pr Christophe Hennequin, Hôpital Saint Louis, Paris

Actualité sur les indications de chirurgie axillaire en chirurgie première,
Pr Emmanuel Barranger
 
Actualité sur la chirurgie axillaire après CNA
Pr Jean-Marc Classe
 
Impact de l’information axillaire sur les indications de traitement néoadjuvant
Dr Joana Ribeiro
 
Actualité sur la place de la radiothérapie axillaire
Pr Christophe Hennequin
 
Conclusion et Réponses aux questions

 

Shooting date : 2023-05-10
Last update : 2023-05-16

Suggestions

Tuesday, November 19th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, November 19th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, November 19th 2024 from 09am to 10:30am (GMT+1)
New York : Tuesday, November 19th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, November 19th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, November 19th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, November 19th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, November 19th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, November 19th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, November 20th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, November 20th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, November 20th 2024 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, November 20th 2024 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, November 20th 2024 from 05am to 06:30am (GMT+1)

Cancer du sein métastatique RH+/HER2- :

individualisation du traitement en 1ère et 2ème ligne

Share
Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 21st 2021 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, December 21st 2021 from 09am to 10:30am (GMT+1)
New York : Tuesday, December 21st 2021 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, December 21st 2021 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, December 21st 2021 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, December 21st 2021 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 21st 2021 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, December 22nd 2021 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, December 22nd 2021 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, December 22nd 2021 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, December 22nd 2021 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, December 22nd 2021 from 05am to 06:30am (GMT+1)

Indication de chimiothérapie néoadjuvante dans la prise en charge des patientes atteintes d’un c...

Share
Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
Honolulu : Tuesday, March 28th 2023 from 08am to 09:30am (GMT+2)
San Francisco : Tuesday, March 28th 2023 from 11am to 12:30pm (GMT+2)
New York : Tuesday, March 28th 2023 from 02pm to 03:30pm (GMT+2)
Buenos Aires : Tuesday, March 28th 2023 from 03pm to 04:30pm (GMT+2)
Reykjavik : Tuesday, March 28th 2023 from 06pm to 07:30pm (GMT+2)
London / Dublin : Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
Paris / Berlin : Tuesday, March 28th 2023 from 08pm to 09:30pm (GMT+2)
Istanbul : Tuesday, March 28th 2023 from 09pm to 10:30pm (GMT+2)
Moscou / Dubaï : Tuesday, March 28th 2023 from 10pm to 11:30pm (GMT+2)
Bangkok : Wednesday, March 29th 2023 from 01am to 02:30am (GMT+2)
Shanghai : Wednesday, March 29th 2023 from 02am to 03:30am (GMT+2)
Tokyo : Wednesday, March 29th 2023 from 03am to 04:30am (GMT+2)
Sydney : Wednesday, March 29th 2023 from 05am to 06:30am (GMT+2)
Wellington : Wednesday, March 29th 2023 from 07am to 08:30am (GMT+2)

La prise en charge des cancers du sein triple négatifs :

intégration des innovations thérapeutiques dans les algorithmes et gestion des effets secondaires

Share
Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Thursday, May 25th 2023 from 07:30am to 09am (GMT+2)
San Francisco : Thursday, May 25th 2023 from 10:30am to 12pm (GMT+2)
New York : Thursday, May 25th 2023 from 01:30pm to 03pm (GMT+2)
Buenos Aires : Thursday, May 25th 2023 from 02:30pm to 04pm (GMT+2)
Reykjavik : Thursday, May 25th 2023 from 05:30pm to 07pm (GMT+2)
London / Dublin : Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Paris / Berlin : Thursday, May 25th 2023 from 07:30pm to 09pm (GMT+2)
Istanbul : Thursday, May 25th 2023 from 08:30pm to 10pm (GMT+2)
Moscou / Dubaï : Thursday, May 25th 2023 from 09:30pm to 11pm (GMT+2)
Bangkok : Friday, May 26th 2023 from 12:30am to 02am (GMT+2)
Shanghai : Friday, May 26th 2023 from 01:30am to 03am (GMT+2)
Tokyo : Friday, May 26th 2023 from 02:30am to 04am (GMT+2)
Sydney : Friday, May 26th 2023 from 04:30am to 06am (GMT+2)
Wellington : Friday, May 26th 2023 from 06:30am to 08am (GMT+2)

Cancer du sein RH+ : Quelles optimisations thérapeutiques en 2L métastatique ?

Share
Scroll Up